Jump to content

Orticumab

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Bender the Bot (talk | contribs) at 02:17, 5 October 2020 (→‎top: HTTP → HTTPS for World Health Organization, replaced: = http://www.who.int/ → =https://www.who.int/). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Orticumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetoxLDL
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII

Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.[1]

References

  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).


Stub icon

This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Orticumab&oldid=981902940"